Low levels of HER2 expression: new ideas for differentiated strategies in the choice of treatment for triple-negative breast cancers. Вопр. онкол. [Internet]. 2023 Mar. 7 [cited 2026 Oct. 14];69(1):38-44. Available from: https://voprosyonkologii.ru/index.php/journal/article/view/1558